Edwards Lifesciences Corp (EW) Stock Price, Quote & News

Company Profile

Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. The company offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband brands. I...

Industry: Medical Devices

Sector: Healthcare

Phone: 949 250 2500

Website: www.edwards.com

Address:

One Edwards Way, Irvine, United States

BreakoutPika Feb. 17 at 6:36 PM

$MT $UAL $EW $KTOS //

0 · Reply

__ChartMenace Feb. 17 at 5:45 PM

$ABNB $EW $NWG $CCL ;

0 · Reply

fjsteven Feb. 17 at 4:54 PM

$EW this is moving today cause MDT released their six and seven year low risk data and it sucked.

1 · Reply

GettnFibbywIT Feb. 17 at 3:23 PM

$EW $XLV $IHI Edwards (EW) is rebounding off the lower boundary of its long‑term rising weekly channel. A weekly close back above the round‑number $80 level and the 7/21/25 weekly close — paired with RSI reclaiming the 50 line — would signal a constructive momentum shift. For traders who use structured credit spreads, a bull put spread placed a few months out with the short strike set below the 10/13/25 weekly low aligns with the underlying support structure and offers a defined‑risk way to potentially express an early bullish reversal thesis. This is not a recommendation to buy or sell, but rather a potential near‑term strategy idea that fits the current technical construct:

0 · Reply

SuperGreenToday Feb. 13 at 1:26 PM

$EW Share Price: $76.43 Contract Selected: Jun 18, 2026 $80 Calls Buy Zone: $3.47 – $4.29 Target Zone: $6.07 – $7.42 Potential Upside: 65% ROI Time to Expiration: 124 Days | Updates via https://fxcapta.com/stockinfo/

1 · Reply

erevnon Feb. 11 at 6:40 PM

Goldman Sachs maintains Edwards Lifesciences $EW at Buy and lowers the price target from $108 to https://marketsblock.com/stock-upgrades-and-downgrades/

0 · Reply

50bps Feb. 11 at 5:10 PM

$EW nice recovery

0 · Reply

ZacksResearch Feb. 11 at 1:26 PM

$EW misses on Q4 EPS but tops revenue estimates — a mixed bag for investors 🤔 - Q4 EPS of 58 cents missed the Zacks Consensus Estimate by 5.89% 📉 - Q4 sales rose 13.3% YoY to $1.57B, beating estimates by 1.99% 🚀 - TAVR segment saw a 12% sales increase, reflecting strong demand Discover the full earnings breakdown here 👉 https://www.zacks.com/stock/news/2853826/ews-q4-earnings-miss-estimates-revenues-up-yy-stock-climbs?cid=sm-stocktwits-2-2853826-body-32973&ADID=SYND_STOCKTWITS_TWEET_2_2853826_BODY_32973

0 · Reply

ZacksResearch Feb. 11 at 12:26 PM

$EW earnings miss… and the stock still climbs? 👀 Q4 earnings came in below estimates, but revenues were up year over year — and the market is clearly focusing on the growth, not the miss. When a stock rallies on an earnings miss, that tells you sentiment and forward expectations may be stronger than the headline suggests. Is this strength sustainable or just a short-term pop? Full breakdown here 👉 https://www.zacks.com/stock/news/2853826/ews-q4-earnings-miss-estimates-revenues-up-yy-stock-climbs?cid=sm-stocktwits-2-2853826-teaser-32968&ADID=SYND_STOCKTWITS_TWEET_2_2853826_TEASER_32968

0 · Reply

Thrasher5699 Feb. 10 at 11:36 PM

$EW Edwards Lifesciences (EW) is currently viewed as moderately undervalued by many Wall Street analysts, though traditional valuation multiples suggest a premium price. As of February 10, 2026, the stock trades around $77.05, while the consensus average price target of $96.77 implies a potential upside of approximately 24.8%.

1 · Reply

Edwards Lifesciences to Present at the Barclays and Leerink Partners Global Healthcare Conferences

Feb 16, 2026, 5:49 AM EST - 7 days ago

Edwards Lifesciences scraps anti-copycat policy, EU drops antitrust investigation

Feb 13, 2026, 7:05 AM EST - 10 days ago

Edwards Lifesciences to Present at Citi's 2026 Unplugged Medtech and Life Sciences Access Day

Feb 12, 2026, 12:26 PM EST - 11 days ago

Halper Sadeh LLC Encourages Edwards Lifesciences Corporation Shareholders to Contact the Firm to Discuss Their Rights

Feb 10, 2026, 7:54 PM EST - 12 days ago

Edwards Lifesciences Corporation (EW) Q4 2025 Earnings Call Transcript

Feb 10, 2026, 4:51 PM EST - 12 days ago

Edwards Lifesciences forecasts 2026 profit above estimates on heart devices strength

Feb 10, 2026, 4:15 PM EST - 12 days ago

Edwards Lifesciences Reports Fourth Quarter Results

Feb 3, 2026, 7:05 AM EST - 20 days ago

Edwards Lifesciences to Host Earnings Conference Call on February 10, 2026

Feb 2, 2026, 7:05 AM EST - 21 days ago

Edwards Lifesciences to Present at the TD Cowen 46th Annual Health Care Conference

Jan 15, 2026, 6:10 AM EST - 5 weeks ago

Wedgewood Partners: Q4 2025 Top Performers And Detractors

AAPL AMZN AVGO CB CDW CPRT GOOGL

Jan 12, 2026, 4:55 PM EST - 5 weeks ago

Edwards Lifesciences Corporation (EW) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Jan 9, 2026, 6:48 PM EST - 6 weeks ago

Edwards Comments on JenaValve Acquisition

Jan 9, 2026, 4:17 PM EST - 6 weeks ago

FTC wins ruling blocking Edwards Lifesciences' acquisition of JenaValve

Dec 24, 2025, 12:45 PM EST - 2 months ago

HALPER SADEH LLC ENCOURAGES EDWARDS LIFESCIENCES CORPORATION SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

Dec 23, 2025, 9:00 AM EST - 2 months ago

FDA Approves Edwards Lifesciences' SAPIEN M3 Mitral Valve Replacement System as First Transseptal Transcatheter Therapy

Dec 18, 2025, 7:05 AM EST - 2 months ago

Edwards Lifesciences to Present at the 44th Annual J.P. Morgan Healthcare Conference

Dec 11, 2025, 8:52 AM EST - 2 months ago

Edwards Lifesciences Corporation (EW) Analyst/Investor Day Transcript

Dec 4, 2025, 9:00 AM EST - 2 months ago

Edwards Lifesciences Reaffirms Strategy for Sustainable, Differentiated Growth at Annual Investor Conference

Nov 25, 2025, 1:24 PM EST - 3 months ago

Top small-cap plays for 2026

A COHR DG TXT VLO

Nov 20, 2025, 8:40 AM EST - 3 months ago

Artisan Global Discovery Fund: Q3 Delivers Strong Results Amid Trimming And Exits

BA BFAM CWAN EPS LSCC MOD MPWR

Nov 9, 2025, 4:00 PM EST - 3 months ago

Edwards Champions American Heart Association Initiative to Reduce Deaths, Improve Care for Patients With Heart Valve Disease

Oct 30, 2025, 9:26 PM EDT - 4 months ago

Edwards Lifesciences Corporation (EW) Q3 2025 Earnings Call Transcript

Oct 30, 2025, 5:02 PM EDT - 4 months ago

Edwards Lifesciences beats quarterly estimates on strength in heart devices

Oct 30, 2025, 4:38 PM EDT - 4 months ago

Edwards Lifesciences CFO Scott Ullem to step down by mid-2026

Oct 30, 2025, 4:15 PM EDT - 4 months ago

Edwards Lifesciences Announces CFO Transition Plan

Oct 30, 2025, 4:13 PM EDT - 4 months ago

Edwards Lifesciences Reports Third Quarter Results

Oct 27, 2025, 8:44 PM EDT - 4 months ago

EW Investor News: Rosen Law Firm Investigates Breaches of Fiduciary Duties by the Directors and Officers of Edwards Lifesciences Corporation – EW

Oct 27, 2025, 3:06 PM EDT - 4 months ago

Successful Patient Outcomes Demonstrated With Edwards' SAPIEN M3 and EVOQUE Systems, New Data Presented at TCT 2025

Oct 27, 2025, 2:22 PM EDT - 4 months ago

Edwards SAPIEN 3 TAVR Delivers Proven Long-term Benefits and Valve Performance, New Data Presented at TCT 2025

Oct 23, 2025, 7:05 AM EDT - 4 months ago

Edwards Lifesciences to Host Earnings Conference Call on October 30, 2025

Oct 22, 2025, 6:31 PM EDT - 4 months ago

Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Edwards Lifesciences Corporation - EW

Oct 16, 2025, 6:00 PM EDT - 4 months ago

EW Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Edwards Lifesciences Corporation – EW

Oct 14, 2025, 2:36 PM EDT - 4 months ago

Edwards Lifesciences: Inflection Incoming, But When?

Aug 29, 2025, 9:09 AM EDT - 6 months ago

Updated ESC/EACTS Guidelines Mark Advancement in Structural Heart Disease Care

Aug 19, 2025, 4:15 PM EDT - 6 months ago

Edwards Lifesciences Announces $500 Million Accelerated Share Repurchase

Aug 14, 2025, 4:16 PM EDT - 6 months ago

Edwards Lifesciences Corporation Investors: Company Investigated by the Portnoy Law Firm

Aug 7, 2025, 9:45 PM EDT - 7 months ago

Baron Capital's Top Health Care Stock Picks And Misses From Q2 2025

ACLX BSX EXAS GH ISRG LLY MASI

Aug 6, 2025, 2:17 PM EDT - 7 months ago

JenaValve Responds to FTC's Action Against Proposed Edwards Lifesciences Acquisition

Aug 6, 2025, 1:41 PM EDT - 7 months ago

FTC seeks to block Edwards Lifesciences' acquisition of JenaValve

Aug 6, 2025, 1:40 PM EDT - 7 months ago

Edwards Lifesciences Comments on FTC's Action to Block Proposed Acquisition of JenaValve

Aug 6, 2025, 12:20 PM EDT - 7 months ago

Edwards Lifesciences Stock: Likely To See Sluggish Price Action Through 2027

Jul 31, 2025, 9:52 AM EDT - 7 months ago

10 stocks favored to gain up to 30% in a sector that has missed this year's rally

BSX CAH DXCM ISRG LLY PODD SYK

Jul 25, 2025, 1:49 PM EDT - 7 months ago

Edwards Lifesciences Lifts 2025 Outlook On Strong First Half Performance

Jul 25, 2025, 9:53 AM EDT - 7 months ago

Edwards Lifesciences Analysts Increase Their Forecasts After Stronger-Than-Expected Q2 Results

Jul 24, 2025, 11:07 PM EDT - 7 months ago

Edwards Lifesciences Corporation (EW) Q2 2025 Earnings Call Transcript

Jul 24, 2025, 4:53 PM EDT - 7 months ago

Edwards Lifesciences raises annual sales forecast on strong demand for heart devices

Jul 24, 2025, 4:15 PM EDT - 7 months ago

Edwards Lifesciences Reports Second Quarter Results

Jul 23, 2025, 9:57 AM EDT - 7 months ago

Five years after COVID, pharma shares languish in US policy limbo

ABBV ABT ALNY AZN LLY MRK NVO

Jul 18, 2025, 7:05 AM EDT - 7 months ago

Edwards Lifesciences to Host Earnings Conference Call on July 24, 2025

BreakoutPika Feb. 17 at 6:36 PM

$MT $UAL $EW $KTOS //

0 · Reply

__ChartMenace Feb. 17 at 5:45 PM

$ABNB $EW $NWG $CCL ;

0 · Reply

fjsteven Feb. 17 at 4:54 PM

$EW this is moving today cause MDT released their six and seven year low risk data and it sucked.

1 · Reply

GettnFibbywIT Feb. 17 at 3:23 PM

0 · Reply

SuperGreenToday Feb. 13 at 1:26 PM

1 · Reply

erevnon Feb. 11 at 6:40 PM

Goldman Sachs maintains Edwards Lifesciences $EW at Buy and lowers the price target from $108 to https://marketsblock.com/stock-upgrades-and-downgrades/

0 · Reply

50bps Feb. 11 at 5:10 PM

$EW nice recovery

0 · Reply

ZacksResearch Feb. 11 at 1:26 PM

0 · Reply

ZacksResearch Feb. 11 at 12:26 PM

0 · Reply

Thrasher5699 Feb. 10 at 11:36 PM

1 · Reply

Thrasher5699 Feb. 10 at 10:05 PM

BUY $EW Great Earnings and 86% owned by institutions !

0 · Reply

Thrasher5699 Feb. 10 at 10:03 PM

BUY $EW

0 · Reply

Thrasher5699 Feb. 10 at 9:57 PM

$EW Going back over 120$ Great earnings!!!

0 · Reply

Thrasher5699 Feb. 10 at 9:51 PM

$EW 120$ here we come!

0 · Reply

StocktwitsEarnings Feb. 10 at 9:33 PM

$EW Q4 '25 Earnings Results & Recap • Reported GAAP EPS of $0.16 down -75.38% YoY • Reported revenue of $1.57B up 13.26% YoY • Edwards Lifesciences has increased confidence in its FY 2026 constant currency sales growth guidance of 8-10% and adjusted EPS of $2.90-$3.05, and projects Q1 2026 sales between $1.55B.

0 · Reply

StocktwitsEarnings Feb. 10 at 9:33 PM

$EW Q4 '25 Earnings Results & Recap • Reported GAAP EPS of $0.16 down -75.38% YoY • Reported revenue of $1.57B up 13.26% YoY • Edwards Lifesciences increased confidence in FY 2026 constant currency sales growth of 8-10% and adjusted EPS of $2.90-$3.05. Edwards projects Q1 2026 sales between $1.55B and $1.63B.

0 · Reply

FannyPackin Feb. 10 at 9:29 PM

$EW would like to see it reclaim 200 week.. will look to add this if it can break 90 and hold later this year..

1 · Reply

DonCorleone77 Feb. 10 at 8:16 PM

$EW Edwards Lifesciences options imply 5.3% move in share price post-earnings Pre-earnings options volume in Edwards Lifesciences is 4.3x normal with calls leading puts 5:4. Implied volatility suggests the market is anticipating a move near 5.3%, or $4.11, after results are released. Median move over the past eight quarters is 3.7%.

0 · Reply

DonCorleone77 Feb. 10 at 7:57 PM

$GILD $HOOD $NET $F $EW Some notable companies reporting after the market close, with earnings consensus estimates: - Gilead (GILD), consensus $1.83 - Robinhood (HOOD), consensus 68c - Cloudflare (NET), consensus 27c - Ford (F), consensus 19c - Edwards Lifesciences (EW), consensus 62c - Zillow (ZG), consensus 40c - Lyft (LYFT), consensus 32c - Freshworks (FRSH), consensus 11c

0 · Reply

Estimize Feb. 10 at 4:00 PM

$EW reports after the close, Estimize Consensus +0.02 EPS and +32.27M Revs compared to WS http://www.estimize.com/ew/fq4-2025?utm_content=p

0 · Reply

OfficialStocktwitsUser Feb. 10 at 3:14 PM

$EW RSI: 25.07, MACD: -1.6990 Vol: 2.52, MA20: 82.06, MA50: 83.87 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

jewell69 Feb. 10 at 5:38 AM

$BSX 3 day rule is over .. wait wait 4 day rule Maybe should look at $EW Edwards Lifescience instead Are we 2 late on $XBI ??

1 · Reply

Market Cap	46.30B
Revenue (ttm)	6.07B
Net Income (ttm)	1.07B
EPS (ttm)	N/A
PE Ratio	30.83
Forward PE	26.65
Profit Margin	17.69%
Debt to Equity Ratio	0.06

Volume	1,703,300
Avg Vol	3,959,204
Day's Range	N/A - N/A
Shares Out	580.30M
Stochastic %K	89%
Beta	0.94
Analysts	Strong Sell
Price Target	$96.11